Vivos Inc. (OTCMKTS:RDGL – Get Free Report) dropped 2.2% on Friday . The company traded as low as $0.11 and last traded at $0.12. Approximately 971,878 shares traded hands during mid-day trading, a decline of 22% from the average daily volume of 1,244,290 shares. The stock had previously closed at $0.12.
Vivos Stock Down 2.2 %
The firm has a market capitalization of $51.13 million, a P/E ratio of -12.17 and a beta of 1.08. The firm has a 50 day moving average of $0.15 and a 200-day moving average of $0.16.
About Vivos
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Further Reading
- Five stocks we like better than Vivos
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- 3 Best Fintech Stocks for a Portfolio Boost
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
